Diagnosis of moyamoya disease using 3-T MRI and MRA: Value of cisternal moyamoya vessels

Neuroradiology

Volumn 54, Issue 10, 2012, Pages 1089-1097

  Sawada, Takeshi ^a   Yamamoto, Akira ^a   Miki, Yukio ^b   Kikuta, Ken Ichiro ^c   Okada, Tomohisa ^a   Kanagaki, Mitsunori ^a   Kasahara, Seiko ^a   Miyamoto, Susumu ^a   Takahashi, Jun C ^a   Fukuyama, Hidenao ^a   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Cisternal moyamoya vessels; Magnetic resonance angiography; Magnetic resonance imaging; Moyamoya disease; T2 weighted imaging

Indexed keywords

ADOLESCENT; ADULT; ANTERIOR CEREBRAL ARTERY; ARTICLE; BASAL GANGLION; BRAIN ANGIOGRAPHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNAL CAROTID ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STAGING; SUZUKI STAGE; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; CAROTID ARTERIES; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MOYAMOYA DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84867872790     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-012-1020-1     Document Type: Article

References (35)

1. Suzuki J, Takaku A (1969) Cerebrovascular moyamoya disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288-299
2. Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR (2009) Moyamoya disease: a summary. Neurosurg Focus 26(4):E11. doi: 10.3171/2009.1.FOCUS08310
3. Takahashi JC, Miyamoto S (2010) Moyamoya disease: recent progress and outlook. Neurol Med Chir (Tokyo) 50(9):824-832. doi: JST.JSTAGE/nmc/50.824
4. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6(7):e22542. doi: 10.1371/journal.pone.0022542
5. Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99(Suppl 2):S238-S240
6. Jones BP, Ganesan V, Saunders DE, Chong WK (2010) Imaging in childhood arterial ischaemic stroke. Neuroradiology 52(6):577-589. doi: 10.1007/s00234-010-0704-7
7. Serdaru M, Gray F, Merland JJ, Escourolle R, Grumbach R (1979) Moyamoya disease and intracerebral hematoma. Clinical pathological report. Neuroradiology 18(1):47-52 (Pubitemid 9222916)
8. Currie S, Raghavan A, Batty R, Connolly DJ, Griffiths PD (2011) Childhood moyamoya disease and moyamoya syndrome: a pictorial review. Pediatr Neurol 44(6):401-413. doi: 10.1016/j.pediatrneurol.2011.02.007
9. Takanashi J (2011) Moyamoya disease in children. Brain Dev 33(3):229-234. doi: 10.1016/j.braindev.2010.09.003
10. Lee DJ, Liebeskind DS (2011) Characterization of inpatient moyamoya in the United States: 1988-2004. Front Neurol 2:43. doi: 10.3389/fneur.2011.00043
11. Houkin K, Aoki T, Takahashi A, Abe H (1994) Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke 25(11):2159-2164 (Pubitemid 24338369)
12. Maki Y, Enomoto T (1988) Moyamoya disease. Childs Nerv Syst 4(4):204-212
13. Tanenbaum LN (2004) 3-T MR imaging: ready for clinical practice. AJNR Am J Neuroradiol 25(9):1626-1627, author reply 1629
14. Thomas SD, Al-Kwifi O, Emery DJ, Wilman AH (2002) Application of magnetization transfer at 3.0 T in three-dimensional time-of-flight magnetic resonance angiography of the intracranial arteries. J Magn Reson Imaging 15(4):479-483. doi: 10.1002/Jmri.10085 (Pubitemid 34252412)
15. Fushimi Y, Miki Y, Kikuta K, Okada T, Kanagaki M, Yamamoto A, Nozaki K, Hashimoto N, Hanakawa T, Fukuyama H, Togashi K (2006) Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology 239(1):232-237. doi: 10.1148/radiol.2383042020
16. Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, Miki Y, Fushmi Y, Yamamoto A, Yamada K, Fukuyama H, Hashimoto N (2005) Asymptomatic microbleeds in moyamoya disease: T2 -weighted gradient-echo magnetic resonance imaging study. J Neurosurg 102(3):470-475. doi: 10.3171/jns.2005.102.3.0470 (Pubitemid 43194038)
17. Mori N, Miki Y, Kikuta K, Fushimi Y, Okada T, Urayama S, Sawamoto N, Fukuyama H, Hashimoto N, Togashi K (2008) Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2 -weighted imaging at 3 Tesla. Invest Radiol 43(8):574-579. doi: 10.1097/RLI.0b013e31817fb432
18. Illner A (2009) Moyamoya. In: Osborn AG, Salzman KL, Barkovich AJ (eds) Diagnostic imaging: brain, 2nd edn. Lippincott Williams & Wilkins, Salt Lake City, pp I-4-46-I-4-49
19. Maeda M, Tsuchida C (1999) Ivy sign on fluid-attenuated inversion-recovery images in childhood moyamoya disease. Am J Neuroradiol 20(10):1836-1838
20. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111(5):927-935. doi: 10.3171/2009.4.JNS081649
21. Hanley JA, Mcneil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839-843 (Pubitemid 13033817)
22. McNemar Q (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12(2):153-157
23. Fukui M (1997) Current state of study on moyamoya disease in Japan. Surg Neurol 47(2):138-143 (Pubitemid 27074166)
24. Fujisawa I, Asato R, Nishimura K, Togashi K, Itoh K, Noma S, Sagoh T, Minami S, Nakano Y, Yonekawa Y et al (1987) Moyamoya disease: MR imaging. Radiology 164(1):103-105 (Pubitemid 17089884)
25. Yamada I, Matsushima Y, Suzuki S (1992) Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography. Radiology 184(3):773-778
26. Battistella PA, Carollo C, Pellegrino PA, Soriani S, Scarpa P (1995) Magnetic resonance angiography in moyamoya disease. Childs Nerv Syst 11(6):329-334
27. Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T (2005) Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 20(5):347-354. doi: 10.1159/000087935 (Pubitemid 41551985)
28. Yamada I, Suzuki S, Matsushima Y (1995) Moyamoya disease: diagnostic accuracy of MRI. Neuroradiology 37(5):356-361
29. Bacigaluppi S, Dehdashti AR, Agid R, Krings T, Tymianski M, Mikulis DJ (2009) The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease: a review. Neurosurg Focus 26(4):E3. doi: 10.3171/2009.01.FOCUS08296
30. Komiyama M, Ishiguro T, Nishikawa M, Yasui T, Morikawa T, Kitano S, Sakamoto H (2002) Constructive interference in steady state imaging of moyamoya disease. Neurol Med Chir (Tokyo) 42(1):11-16, discussion 17 (Pubitemid 34135566)
31. Yao B, Li TQ, van Gelderen P, Shmueli K, de Zwart JA, Duyn JH (2009) Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 44(4):1259-1266. doi: 10.1016/j.neuroimage.2008.10.029
32. Hallemeier CL, Rich KM, Grubb RL, Chicoine MR, Moran CJ, Cross DT, Zipfel GJ, Dacey RG, Derdeyn CP (2006) Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37(6):1490-1496. doi: 10.1161/01.Str.0000221787.70503.Ca (Pubitemid 44305731)
33. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC (2004) Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54(4):840-845. doi: 10.1227/01.Neu. 0000114140.41509.14
34. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100(2):142-149 (Pubitemid 38141339)
35. Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360(12):1226-1237. doi: 10.1056/NEJMra0804622